Business Context and Reporting Period
This Form 8-K Current Report was filed by Predictive Oncology Inc. (not Axe Compute Inc.) on July 8, 2025, covering the event date of July 1, 2025. The company, incorporated in Delaware and trading on the NASDAQ Capital Market under the symbol POAI, reported the entry into a Standby Equity Purchase Agreement (SEPA).
Key Financial Metrics and Agreement Terms
- Commitment Amount: Up to $10 million in common stock.
- Investor: YA II PN, LTD., a Cayman Islands exempt limited company.
- Pricing Mechanism: Shares are sold at 96% of the lowest daily Volume Weighted Average Price (VWAP) during the three trading days following an Advance Notice, subject to a minimum acceptable price.
- Issuance Cap: Limited to 1,921,706 shares (19.99% of outstanding shares) unless shareholder approval is obtained or the average sale price exceeds $0.83 per share.
- Ownership Limit: Investor beneficial ownership capped at 4.99% of outstanding voting power.
- Upfront Costs: A $25,000 structuring fee and 120,482 shares of common stock (representing a 1.00% commitment fee) were issued to the Investor upon execution.
- Term: The agreement terminates after 36 months or upon the full sale of the $10 million commitment amount.
Material Changes and Liquidity Impact
The filing does not provide comparative financial statements, revenue, profit, or cash flow data for the reporting period. The primary material change is the establishment of a potential liquidity facility. The company expects to use net proceeds from future sales under the SEPA for working capital and general corporate purposes. Immediate liquidity impact includes the issuance of 120,482 shares and a cash outflow of $25,000 for fees.
Guidance, Risks, and Contingencies
- Registration Requirement: The company cannot request any advances until a registration statement for the resale of shares is filed with the SEC and declared effective.
- Termination Rights: The company may terminate the SEPA at no cost with five trading days' prior written notice, provided no outstanding Advance Notices exist.
- Market Conditions: The ability to sell shares is contingent on the daily VWAP meeting the minimum acceptable price set by the company in each Advance Notice.
- Regulatory Compliance: Issuances are subject to Nasdaq rules regarding the 19.99% exchange cap and the 4.99% beneficial ownership limit for the investor.
Investor Verification Checklist
- Verify the effectiveness of the Registration Statement required to enable share sales under the SEPA.
- Confirm the current market price of POAI relative to the $0.83 threshold required to bypass the 19.99% issuance cap.
- Review the full text of the SEPA (Exhibit 10.1) for specific covenants and indemnification obligations.
- Monitor future filings for the issuance of Advance Notices and the actual volume of shares sold.
- Assess the dilution impact of the 120,482 shares already issued as a commitment fee.